Gersony W M
Am J Cardiol. 1998 May 1;81(9):1162-4. doi: 10.1016/s0002-9149(98)00115-5.
Intravenous immunoglobulin is used to prevent coronary artery involvement in patients with acute Kawasaki disease. In this issue of the journal, Beiser et al provide a scoring system that is invoked 24 hours after gamma globulin therapy to predict risk for coronary involvement. This instrument would be useful for pediatric cardiologists and pediatricians in planning later management of patients with Kawasaki disease and counseling parents regarding long-term outcome.
静脉注射免疫球蛋白用于预防急性川崎病患者的冠状动脉受累。在本期杂志中，贝泽尔等人提供了一种评分系统，该系统在丙种球蛋白治疗24小时后使用，以预测冠状动脉受累风险。该工具对于儿科心脏病专家和儿科医生规划川崎病患者的后续治疗以及就长期预后向家长提供咨询将很有用。
